These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 17178987)

  • 1. Superficial venous thrombophlebitis as the initial manifestation of hypereosinophilic syndrome: study of the first 3 cases.
    Terrier B; Piette AM; Kerob D; Cordoliani F; Tancrède E; Hamidou L; Lebbé C; Blétry O; Kahn JE
    Arch Dermatol; 2006 Dec; 142(12):1606-10. PubMed ID: 17178987
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mucosal ulcerations revealing primitive hypereosinophilic syndrome.
    Barouky R; Bencharif L; Badet F; Salles G; Vital Durand D; Rousset H
    Eur J Dermatol; 2003; 13(2):207-8. PubMed ID: 12695143
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Alpha interferon treatment in idiopathic hypereosinophilic syndrome resistant to conventional therapy].
    Esteve J; Cervantes F; Bosch F; Cobo F; Montserrat E; Rozman C
    Med Clin (Barc); 1996 Mar; 106(8):304-6. PubMed ID: 8667689
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Endomyocardial disease as the first manifestation of hypereosinophilic syndrome].
    Poreba M; Rostoff P; Konduracka E; Pikul P; Rucińska M; Pasowicz M; Piwowarska W
    Kardiol Pol; 2010 Apr; 68(4):440-5. PubMed ID: 20425707
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypereosinophilic syndrome: an update.
    Wilkins HJ; Crane MM; Copeland K; Williams WV
    Am J Hematol; 2005 Oct; 80(2):148-57. PubMed ID: 16184589
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Horton's disease and hypereosinophilic syndrome: a non-fortuitous association].
    Liozon E; Soria P; Gissot V; Loustaud V; Jauberteau MO; Vidal E
    Ann Med Interne (Paris); 2000 Nov; 151(7):603-605. PubMed ID: 11139663
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Isolated mucosal ulcers disclosing idiopathic hypereosinophilic syndrome].
    Billon C; Gautier C; Villaret E; Ducos MH; Martin JC; Geniaux M
    Ann Dermatol Venereol; 1997; 124(3):248-50. PubMed ID: 9686058
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Interferon-alpha therapy in the myeloproliferative variants of hypereosinophilic syndrome].
    Kobayashi M; Katayama T; Ochiai S; Yoshida M; Kaito K; Masuoka H; Shimada T; Nishiwaki K; Sakai O
    Rinsho Ketsueki; 1993 Mar; 34(3):367-72. PubMed ID: 8479090
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Erythrodermic cutaneous T cell lymphoma with hypereosinophilic syndrome: Treatment with interferon alfa and extracorporeal photopheresis.
    Lee CH; Mamelak AJ; Vonderheid EC
    Int J Dermatol; 2007 Nov; 46(11):1198-204. PubMed ID: 17988344
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypereosinophilic syndrome: case presentation and update.
    Leiferman KM; Gleich GJ
    J Allergy Clin Immunol; 2004 Jan; 113(1):50-8. PubMed ID: 14713907
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypereosinophilia with systemic thrombophlebitis.
    Kanno H; Ouchi N; Sato M; Wada T; Sawai T
    Hum Pathol; 2005 May; 36(5):585-9. PubMed ID: 15948128
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Obstructive prosthetic mitral valve thrombosis in idiopathic hypereosinophilic syndrome: a case report and review of the literature.
    Hii MW; Firkin FC; MacIsaac AI; Yii M
    J Heart Valve Dis; 2006 Sep; 15(5):721-5. PubMed ID: 17044382
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Deep venous thrombosis in hypereosinophilic syndrome.
    Valente O; Scarpinella-Bueno MA
    Am Fam Physician; 1994 Oct; 50(5):921-2. PubMed ID: 7942410
    [No Abstract]   [Full Text] [Related]  

  • 14. Hypereosinophilic syndromes.
    Roufosse FE; Goldman M; Cogan E
    Orphanet J Rare Dis; 2007 Sep; 2():37. PubMed ID: 17848188
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Treatment of hypereosinophilic syndromes of myeloproliferative expression with the combination of hydroxyurea and interferon alpha. Apropos of 7 cases].
    Coutant G; Blétry O; Prin L; Hauteville D; de Puyfontaine O; Abgrall JF; Godeau P
    Ann Med Interne (Paris); 1993; 144(4):243-50. PubMed ID: 8368716
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Complete remission of hypereosinophilic syndrome after interferon-alpha therapy: report of a case and literature review.
    Yoon TY; Ahn GB; Chang SH
    J Dermatol; 2000 Feb; 27(2):110-5. PubMed ID: 10721659
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hypereosinophilic syndrome in an atopic patient.
    Neve S; Beukers S; Kirtschig G
    Clin Exp Dermatol; 2009 Dec; 34(8):e643-6. PubMed ID: 19538189
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Hypereosinophilic syndrome with DIC treated successfully with a combination of high-dose methylprednisolone and cyclosporin A].
    Fukuta A; Hara T; Tsurumi H; Moriwaki H
    Rinsho Ketsueki; 2001 Nov; 42(11):1145-7. PubMed ID: 11808087
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Idiopathic hypereosinophilic syndrome revealed by central nervous system dysfunction.
    Lebbink J; Laterre EC
    Acta Neurol Belg; 1996 Jun; 96(2):137-40. PubMed ID: 8711988
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Central nervous system involvement of hypereosinophilic syndrome: a report of 10 cases and a literature review.
    Lee D; Ahn TB
    J Neurol Sci; 2014 Dec; 347(1-2):281-7. PubMed ID: 25455301
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.